Browsing by Yonsei Author : Ha, Min Jin

eperson profile image
Name:
Ha, Min Jin [하민진]
Department :
Graduate School of Public Health (보건대학원) - Graduate School of Public Health (보건대학원)

Keyword Cloud

Researcher Network

Showing results 1 to 15 of 15

This table browses all dspace content
Issue DateTitleJournal Title
2024Seroprevalence of anti-diphtheria toxoid antibody and implications for vaccination policy in Vietnam's South-central coast: a cross-sectional study BMC INFECTIOUS DISEASES
2024Association between sleep patterns and alcohol use disorders in workers PLOS ONE
2024Assessment of Patient-Derived Xenograft Growth and Antitumor Activity: The NCI PDXNet Consensus Recommendations MOLECULAR CANCER THERAPEUTICS
2024Association between the utilization of senior centers and participation in health check-ups SCIENTIFIC REPORTS
2024Effect of the peripartum depressive symptoms on the Internet use disorder of their offspring in late childhood: retrospective longitudinal study SCIENTIFIC REPORTS
2023Efficacy of futibatinib, an irreversible fibroblast growth factor receptor inhibitor, in <i>FGFR</i>-altered breast cancer SCIENTIFIC REPORTS
2023Association between changes in having of cancer patients in the family and depression: A longitudinal panel study JOURNAL OF AFFECTIVE DISORDERS
20233-Phosphoinositide-dependent kinase 1 drives acquired resistance to osimertinib COMMUNICATIONS BIOLOGY
2023Estimating causal effects with hidden confounding using instrumental variables and environments Electronic Journal of Statistics
2023A unified mediation analysis framework for integrative cancer proteogenomics with clinical outcomes BIOINFORMATICS
2022A Bayesian precision medicine framework for calibrating individualized therapeutic indices in cancerANNALS OF APPLIED STATISTICS
2022Consensus subtypes of hepatocellular carcinoma associated with clinical outcomes and genomic phenotypesHEPATOLOGY
2022CombPDX: a unified statistical framework for evaluating drug synergism in patient-derived xenografts SCIENTIFIC REPORTS
2022Palbociclib plus endocrine therapy significantly enhances overall survival of HR+/HER2- metastatic breast cancer patients compared to endocrine therapy alone in the second-line setting: A large institutional studyINTERNATIONAL JOURNAL OF CANCER
2022TUSC2 immunogene enhances efficacy of chemo-immuno combination on KRAS/LKB1 mutant NSCLC in humanized mouse model COMMUNICATIONS BIOLOGY
1

Browse

Links